Domestic pharmaceutical firms urged to augment actual R&D investment
Although some leading pharmaceutical firms have embarked for their sizable investments in R&D new drug projects, the majority of domestic pharmaceutical firms have concentrated their R&D outlays on labor costs, thus causing suspicions on the tangible outcome in the pharmaceutical communit...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
